Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teflaro in pediatric ABSSSI
NCT01400867Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Dec 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of ceftaroline fosamil in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Forest Laboratories. Started Dec 2011; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT01400867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01400867.